Research Index entry · Trial
AV-1959R, a vaccine meant to prevent Alzheimer’s, got FDA Fast Track
- Evidence
- People · first safety trial
- Source
- prnewswire.com
- Added
- 20 October 2026
What it is
AV-1959R, from Nuravax, is a vaccine meant to teach the body to fight amyloid on its own. It’s for people who have the plaque protein building up but no symptoms yet. In October 2026 the FDA gave it Fast Track, which means more contact with the agency and a possibly quicker review, not approval. A first trial in 16 people, published in Molecular Neurodegeneration, found it safe, and everyone who got the vaccine made antibodies.
Where it stands
- Lab discovery
- Animal studies
- First studies in people
- Large trials
- Approved
Early. A trial of about 160 people comes next.
Update timeline
What changed
Newest first. Only changes to the subject itself appear here: new information, or something proven wrong.
- WatchingThe Scouts look again every Friday
Only new information or a correction shows up here, not another mention of the same thing.
- Update